These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19406493)

  • 21. Effect of kidney disease on acute coronary syndrome.
    Rodrigues FB; Bruetto RG; Torres US; Otaviano AP; Zanetta DM; Burdmann EA
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1530-6. PubMed ID: 20576827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of acute coronary syndromes in patients with renal dysfunction.
    Melloni C; Mahaffey KW
    Curr Opin Cardiol; 2008 Jul; 23(4):320-6. PubMed ID: 18520715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Riba AL; Goswami RG; Peacock WF; Pollack CV; Collins SP; Gibler WB; Ohman EM; Peterson ED;
    Am J Cardiol; 2006 Jun; 97(12):1707-12. PubMed ID: 16765118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
    Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB
    Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Tonev ST; Spinler SA; Levine GN; Gallo R; Ducas J; Goodman SG; Antman EM; Becker RC; Langer A; White HD; Aylward PE; Col JJ; Ferguson JJ; Califf RM;
    Int J Cardiol; 2010 Mar; 139(2):123-33. PubMed ID: 19012977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
    Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
    Cohen M; Diez J; Fry E; Rao SV; Ferguson JJ; Zidar J; Levine G; Shani J
    J Invasive Cardiol; 2006 Dec; 18(12):617-39. PubMed ID: 17197714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of serum creatinine in non-ST-elevation acute coronary syndrome].
    Fácila L; Núñez J; Bodí V; Sanchís J; Bertomeu-González V; Consuegra L; Pellicer M; Ferrero A; Sanjuán R; Llácer A
    Rev Esp Cardiol; 2006 Mar; 59(3):209-16. PubMed ID: 16712744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends in management and outcomes of patients with acute coronary syndrome according to renal function.
    Shuvy M; Chen S; Vorobeichik D; Krashin E; Shlomo N; Goldenberg I; Pereg D
    Int J Cardiol; 2017 Apr; 232():48-52. PubMed ID: 28089153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?".
    Abu-Assi E; Ferreira-González I; Ribera A; Marsal JR; Cascant P; Heras M; Bueno H; Sánchez PL; Arós F; Marrugat J; García-Dorado D; Peña-Gil C; González-Juanatey JR; Permanyer-Miralda G
    Am Heart J; 2010 Nov; 160(5):826-834.e1-3. PubMed ID: 21095268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal failure stages as predictors of mortality following acute coronary syndrome].
    Sanchez Hidalgo A; Pou M; Leiro R; López Gómez D; Martínez Ruiz M; Saurina A; Esteve V; Fulquet M; Ramírez de Arellano M; de Miguel M
    Nefrologia; 2009; 29(1):53-60. PubMed ID: 19240772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.
    Mehta RH; Chen AY; Pollack CV; Roe MT; Zalenski RJ; Clements EA; Gibler WB; Ohman EM; Harrington RA; Peterson ED
    Am J Cardiol; 2006 Sep; 98(5):624-7. PubMed ID: 16923449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.